New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in ...

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three ...

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

There are four main types of multiple sclerosis (MS), with relapsing remitting MS (RRMS) being the most common. However, some people who have RRMS may eventually develop secondary progressive ...

This event is supported by Viatris. CRANBURY, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Neurology Live ® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased to announce the 2025 Giants of ...

"I don’t really leave the house anymore," the actress, who was diagnosed with multiple sclerosis in 2021, said Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared ...

Christina Applegate is continuing to speak candidly about her battle with multiple sclerosis. The "Dead to Me" star, 53, became emotional discussing her health in an episode of "Conan O'Brien ...